AU2001259205A1 - The use of bacterial phage associated lysing enzymes for treating various illnesses - Google Patents

The use of bacterial phage associated lysing enzymes for treating various illnesses

Info

Publication number
AU2001259205A1
AU2001259205A1 AU2001259205A AU5920501A AU2001259205A1 AU 2001259205 A1 AU2001259205 A1 AU 2001259205A1 AU 2001259205 A AU2001259205 A AU 2001259205A AU 5920501 A AU5920501 A AU 5920501A AU 2001259205 A1 AU2001259205 A1 AU 2001259205A1
Authority
AU
Australia
Prior art keywords
treating various
bacterial phage
phage associated
various illnesses
lysing enzymes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001259205A
Inventor
Vincent Fischetti
Lawrence Loomis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New Horizons Diagnostics Corp
Original Assignee
New Horizons Diagnostics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/560,650 external-priority patent/US6752988B1/en
Priority claimed from US09/752,732 external-priority patent/US6583872B2/en
Application filed by New Horizons Diagnostics Corp filed Critical New Horizons Diagnostics Corp
Publication of AU2001259205A1 publication Critical patent/AU2001259205A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2001259205A 2000-04-28 2001-04-30 The use of bacterial phage associated lysing enzymes for treating various illnesses Abandoned AU2001259205A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/560,650 US6752988B1 (en) 2000-04-28 2000-04-28 Method of treating upper resiratory illnesses
US09560650 2000-04-28
US09752732 2001-01-03
US09/752,732 US6583872B2 (en) 2000-02-14 2001-01-03 Double beam spectrophotometer
PCT/US2001/013649 WO2001082945A2 (en) 2000-04-28 2001-04-30 The use of bacterial phage associated lysing enzymes for treating various illnesses

Publications (1)

Publication Number Publication Date
AU2001259205A1 true AU2001259205A1 (en) 2001-11-12

Family

ID=27072426

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001259205A Abandoned AU2001259205A1 (en) 2000-04-28 2001-04-30 The use of bacterial phage associated lysing enzymes for treating various illnesses

Country Status (3)

Country Link
US (1) US20020187136A1 (en)
AU (1) AU2001259205A1 (en)
WO (1) WO2001082945A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2513571A1 (en) * 2003-01-16 2004-08-05 New Horizons Diagnostics Corporation The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
US20060270040A1 (en) * 2005-05-26 2006-11-30 Conjugon, Inc. Compositions and methods for treating tissue
IE20060488A1 (en) * 2006-06-29 2008-01-09 Teagasc Agric Food Dev Authori Recombinant staphylococcal phage lysin as an antibacterial agent
EP2144625B1 (en) * 2006-12-05 2022-02-09 Marizyme, Inc. A controlled release enzymatic composition and methods of use
WO2009114520A2 (en) * 2008-03-10 2009-09-17 Pharmain Corporation Compositions for treatment with metallopeptidases, methods of making and using the same
WO2013112865A1 (en) 2012-01-27 2013-08-01 The Trustees Of The University Of Pennsylvania Diagnosis and treatment for respiratory tract diseases
US20150150995A1 (en) * 2012-08-09 2015-06-04 Pono Corporation Conjugated anti-microbial compounds and conjugated anti-cancer compounds and uses thereof
BR112017019413A2 (en) * 2015-03-12 2018-05-02 Micreos Human Health Bv combination of a bactericidal agent with a lysosomotropic alkalizing agent for the treatment of a bacterial infection
EP3522914B1 (en) * 2016-10-07 2023-03-08 Micreos Human Health B.V. Vasoconstrictive and antibacterial combination treatment for rosacea
CN111378638B (en) * 2018-12-29 2023-05-05 江苏万邦医药科技有限公司 Helicobacter pylori phage lyase and preparation method thereof
WO2022195115A1 (en) 2021-03-19 2022-09-22 Eligo Bioscience Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysins for treating subacute cutaneous lupus erythematosus
US11633348B2 (en) 2021-03-19 2023-04-25 Eligo Bioscience Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins
WO2023055434A1 (en) * 2021-09-29 2023-04-06 Bioharmony Therapeutics Inc. Endolysin polypeptide compositions and methods of use

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983209A (en) * 1975-01-28 1976-09-28 Alza Corporation Method for treating burns
US4122158A (en) * 1976-09-23 1978-10-24 Alza Corporation Topical therapeutic preparations
WO1988002781A1 (en) * 1986-10-08 1988-04-21 David Bernstein Method for exposing group a streptococcal antigens and an improved diagnostic test for the identification of group a streptococci
US4885163A (en) * 1987-02-24 1989-12-05 Eli Lilly And Company Topical use of IGF-II for wound healing
US5162226A (en) * 1987-08-24 1992-11-10 University Of Tennessee Research Corp. (U.T.R.C.) Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
US4957686A (en) * 1990-02-06 1990-09-18 Norris Alan H Use of bacteriophages to inhibit dental caries
GB2255561B (en) * 1991-04-20 1995-06-21 Agricultural & Food Res Lysins from bacteriophages
US6033884A (en) * 1992-03-20 2000-03-07 Baylor College Of Medicine Nucleic acid transporter systems and methods of use
JP3345133B2 (en) * 1992-12-21 2002-11-18 サンスター株式会社 Toothpaste composition
US5605793A (en) * 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
EP0755441A4 (en) * 1994-04-05 2000-01-26 Exponential Biotherapies Inc Antibacterial therapy with genotypically modified bacteriophage
EP0776163A4 (en) * 1994-09-09 1999-11-24 Univ Maryland Bacteriophage-encoded enzymes for the treatment and prevention of dental caries and periodontal diseases
US6187757B1 (en) * 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
GB9513683D0 (en) * 1995-07-05 1995-09-06 Ciba Geigy Ag Products
JP3440694B2 (en) * 1996-05-16 2003-08-25 ライオン株式会社 Oral composition
CA2235655C (en) * 1997-04-24 2008-01-22 Sunstar Inc. Oral compositions comprising porous calcium carbonate
AU754806B2 (en) * 1997-07-23 2002-11-28 Ambi Inc. Pharmaceutical compositions containing lysostaphin alone or in combination with an antibiotic for the treatment of staphylococcal infections
US6326002B1 (en) * 1997-10-31 2001-12-04 New Horizons Diagnostics Corporation Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract
US6264945B1 (en) * 1997-10-31 2001-07-24 Vincent A Fischetti Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
WO2000050069A1 (en) * 1999-02-25 2000-08-31 New Horizons Diagnostics, Inc. A means for the prophylactic and therapeutic treatment of streptococcal infections
US6423299B1 (en) * 1997-10-31 2002-07-23 Vincent Fischetti Composition for treatment of a bacterial infection of an upper respiratory tract
US6335012B1 (en) * 1997-10-31 2002-01-01 Vincent Fischetti Use of bacterial phage associated lysing enzymes for treating bacterial infections of the mouth and teeth
US6056954A (en) * 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US6254866B1 (en) * 1997-10-31 2001-07-03 New Horizons Diagnostics Corporation Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract
US5997862A (en) * 1997-10-31 1999-12-07 New Horizons Diagnostics Corporation Therapeutic treatment of group A streptococcal infections
US6248324B1 (en) * 1997-10-31 2001-06-19 Vincent Fischetti Bacterial phage associated lysing enzymes for treating dermatological infections
US6277399B1 (en) * 1997-10-31 2001-08-21 New Horizon Diagnostics Corporation Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
US6056955A (en) * 1999-09-14 2000-05-02 Fischetti; Vincent Topical treatment of streptococcal infections

Also Published As

Publication number Publication date
WO2001082945B1 (en) 2002-05-02
WO2001082945A2 (en) 2001-11-08
WO2001082945A3 (en) 2002-04-04
US20020187136A1 (en) 2002-12-12

Similar Documents

Publication Publication Date Title
HUP0203523A3 (en) The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses
MXPA03005960A (en) Novel mixtures of microbial enzymes.
AU2002227342A1 (en) Method of accelerating media transfer
AUPQ899700A0 (en) Probiotic recolonisation therapy
AU2002242633A1 (en) Fermentation process including the use of enzymes
AU2002219229A1 (en) Means for the diagnosis and therapy of CTCL
AU2001220981A1 (en) Single operator exchange catheters and methods of use
AU2001259205A1 (en) The use of bacterial phage associated lysing enzymes for treating various illnesses
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2001236052A1 (en) Urease inhibitors
AU2002220378A1 (en) Regulation of bacterial virulence
MXPA03005097A (en) Process for the isolation and purification of epothilones.
AU7842700A (en) Selective isolation of bacterial mrna
AU7272900A (en) Phage resistant bacteria
AU2001253064A1 (en) Media exchange system and process
AU2001268153A1 (en) Processing of plasmid-containing fluids
AU2003279247A1 (en) The use of bacterial phage associated lysing proteins for treating bacterial dental caries
AU2001285276A1 (en) Microorganisms and assays for the identification of antibiotics
AU4547600A (en) Bacterial culture
AU2001282132A1 (en) Isolation and sequencing of the pknb gene of c. glutamicum
AU4795000A (en) Bacteria transformation kit
AU2002241706A1 (en) Bacterial promoters and methods of use
AU2001243380A1 (en) Anonymous id
AU2002365651A1 (en) Bacterial enzyme inhibitors
AU2001283465A1 (en) Antisense rna expression strategies effective against streptococcus thermophilus bacteriophage